Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_provenance.
- NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_assertion description "[The DNA repair enzyme O(6)-methylguanine DNA methyltransferase (MGMT) may cause resistance to DNA-alkylating drugs commonly used in the treatment of anaplastic oligodendrogliomas and other malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_provenance.
- NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_assertion evidence source_evidence_literature NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_provenance.
- NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_assertion SIO_000772 15455350 NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_provenance.
- NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_assertion wasDerivedFrom befree-2016 NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_provenance.
- NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_assertion wasGeneratedBy ECO_0000203 NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_provenance.
- befree-2016 importedOn "2016-02-19" NP462447.RA3oXpPu8-U-6SptFqxTHnz2Q0v3roeKv_hdxjXs6WpKM130_provenance.